Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Wednesday, February 25, 2015
Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined...
read more
HUYABIO has entered into a clinical collaboration agreement with Bristol-Myers Squibb to evaluate the combination of HUYABIO's HBI-8000.
read more
Wednesday, April 01, 2020
I-Mab announced a strategic partnership with Kalbe Genexine Biologics.
read more
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
read more
Friday, November 08, 2019
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year IDIQ to provide process development activities and production of a vaccine against the RSV.
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted two additional abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the...
read more
Wednesday, April 15, 2020
Immunoprecise Antibodies announced has entered into a research license agreement with Janssen Research & Development.
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more
Monday, December 23, 2019
Lacutamab will not be administered to new patients in the TELLOMAK trial until additional feedback is received from the respective regulatory agencies overseeing our clinical trial.
read more
Tuesday, October 15, 2019
Innoveix Pharmaceuticals is voluntarily recalling all sterile compounded drug products, within expiry, to the consumer level
read more
Tuesday, November 08, 2022
Insilico Medicine, a clinical stage artificial intelligence driven drug discovery company, announced a multi-year, multi-target strategic research collaboration with Sanofi. Under the terms of the agreement, the collaboration will leverage Insilico ...
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Tuesday, February 20, 2018
Ionis Pharmaceuticals has licensed IONIS-AZ5-2.5Rx (AZD2373) to AstraZeneca.
read more
Thursday, November 16, 2017
Ionis Pharmaceuticals has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech for which Ionis earned $5 million.
read more